Company Overview of SomantiX B.V.
SomantiX B.V., a biotech company, focuses on the development of angiogenesis inhibitors for the treatment of solid cancers through targeting of tumor blood vessels. The company was founded in 2008 and is based in Bilthoven, the Netherlands.
Professor Bronkhorstlaan 10-92
Bilthoven, 3723 MB
Founded in 2008
31 30 229 6092
Key Executives for SomantiX B.V.
Similar Private Companies By Industry
|ACS Biomarker B.V.||Europe|
|Agventure Exploitatie BV||Europe|
|Alloksys Life Sciences BV||Europe|
|Amarna Therapeutics B.V.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact SomantiX B.V., please visit www.somantix.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.